Q4 2017 Holdings
Filed 2018-02-13 | 3 holdings | $125.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revance Therapeutics, Inc.(RVNCEUR) | COM | 761330109 | $110.7K | 3,096,650 | 88.1% |
| Myovant Sciences Ltd. | COM | G637AM102 | $15.0K | 1,188,361 | 11.9% |